Nitric oxide as a marker for evaluation of treatment effect of cyclosporine A in patients with bladder pain syndrome/interstitial cystitis type 3C

References

• van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 2008;53:60–7.
   PubMed Web of Science ®Google Scholar
• Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001;357:593–615.
   PubMed Web of Science ®Google Scholar
• Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993;6:1368–70.
   PubMed Web of Science ®Google Scholar
• Lundberg JO, Hellstrom PM, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994;344:1673–4.
   PubMed Web of Science ®Google Scholar
• Hosseini A, Ehrén I, Wiklund NP. Nitric oxide as an objective marker for evaluation of treatment response in patients with classic interstitial cystitis. J Urol 2004;172:2261–5.
   PubMed Web of Science ®Google Scholar
• Logadottir YR, Ehrén I, Fall M, Wiklund NP, Peeker R. Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis. J Urol 2004;171:1148–50; discussion 50–1.
   PubMed Web of Science ®Google Scholar
• Lee KH, Choi SJ, Lee JH, Kim S, Seol M, Lee YS, et al. Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study. Bone Marrow Transplant 2004;34:627–36.
   PubMedGoogle Scholar
• Maza A, Montaudie H, Sbidian E, Gallini A, Aractingi S, Aubin F, et al. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. J Eur Acad Dermatol Venereol 2011;25:19–27.
   PubMed Web of Science ®Google Scholar
• Sternthal MB, Murphy SJ, George J, Kornbluth A, Lichtiger S, Present DH. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. Am J Gastroenterol 2008;103:937–43.
   PubMed Web of Science ®Google Scholar
• Dijkmans B, Gerards A. Cyclosporin in rheumatoid arthritis: monitoring for adverse effects and clinically significant drug interactions. BioDrugs 1998;10:437–45.
   PubMed Web of Science ®Google Scholar
• Forsell T, Ruutu M, Isoniemi H, Ahonen J, Alfthan O. Cyclosporine in severe interstitial cystitis. J Urol 1996;155:1591–3.
   PubMed Web of Science ®Google Scholar
• Sairanen J, Forsell T, Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol 2004;171:2138–41.
   PubMed Web of Science ®Google Scholar
• Hamalainen M, Lahti A, Moilanen E. Calcineurin inhibitors, cyclosporin A and tacrolimus inhibit expression of inducible nitric oxide synthase in colon epithelial and macrophage cell lines. Eur J Pharmacol 2002;448:239–44.
   PubMed Web of Science ®Google Scholar
• Strestikova P, Otova B, Filipec M, Masek K, Farghali H. Different mechanisms in inhibition of rat macrophage nitric oxide synthase expression by FK 506 and cyclosporin A. Immunopharmacol Immunotoxicol 2001;23:67–74.
   PubMed Web of Science ®Google Scholar
• Marumo T, Nakaki T, Hishikawa K, Suzuki H, Kato R, Saruta T. Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells. Hypertension 1995;25:764–8.
   PubMed Web of Science ®Google Scholar
• Farmaceutiska Specialiteter i Sverige (Swedish National Formulary). www.fass.se.
   Google Scholar
• Pham CQ, Efros CB, Berardi RR. Cyclosporine for severe ulcerative colitis. Ann Pharmacother 2006;40:96–101.
   PubMedGoogle Scholar
• O'Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology 1997;49:58–63.
   PubMed Web of Science ®Google Scholar
• Ehrén I, Hosseini A, Herulf M, Lundberg JO, Wiklund NP. Measurement of luminal nitric oxide in bladder inflammation using a silicon balloon catheter: a novel minimally invasive method. Urology 1999;54:264–7.
   PubMedGoogle Scholar
• Lubeck DP, Whitmore K, Sant GR, Alvarez-Horine S, Lai C. Psychometric validation of the O'Leary–Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium. Urology 2001;57:62–6.
   PubMed Web of Science ®Google Scholar
• Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology 2000;47:119–25.
   PubMed Web of Science ®Google Scholar
• Koskela LR, Thiel T, Ehren I, De Verdier PJ, Wiklund NP. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis. J Urol 2008;180:737–41.
   PubMed Web of Science ®Google Scholar
• Nazif O, Teichman JM, Gebhart GF. Neural upregulation in interstitial cystitis. Urology 2007;69:24–33.
   PubMed Web of Science ®Google Scholar
• Erickson DR, Tomaszewski JE, Kunselman AR, Stetter CM, Peters KM, Rovner ES, et al. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol 2008;179:1850–6.
   PubMed Web of Science ®Google Scholar